Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Patients With Newly Diagnosed Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor

NCT00085202 is registered in ClinicalTrials.gov with St. Jude Children's Research Hospital as lead sponsor.

NCT NCT00085202
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00085202 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Patients With Newly Diagnosed Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor
Lead sponsor
St. Jude Children's Research Hospital
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2003
Completion date
December 31, 2023
Enrollment
416 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

brain and central nervous system tumors